MDT Stock Analysis: Why Medtronic PLC Scored 33% in Stock Value Finder

Research updated: October 21, 2026

Medtronic PLC (MDT) Stock Analysis

Medtronic PLC is a leading global medical technology company based in Ireland with operations spanning across various countries worldwide. The firm specializes in the development, manufacturing, and marketing of medical devices designed to improve patient health outcomes. This article aims to provide an educational review of Medtronic PLC using StockValueFinder's analytical framework.

#### Why the StockValueFinder Score Matters

StockValueFinder evaluates stocks based on a comprehensive set of financial metrics, assigning each stock a score out of 100%. For Medtronic PLC (MDT), this score is currently at 33%, which falls below the threshold often considered favorable by many investors. The rating associated with this score is "AVOID," indicating that according to StockValueFinder's criteria, MDT may not be a strong candidate for investment based on its current financial metrics.

#### EPS Strength and Consistency

Earnings Per Share (EPS) measures how much profit a company generates per outstanding share of stock. A consistent and growing EPS over time is crucial as it indicates steady profitability and growth potential. For Medtronic PLC, the EPS test did not pass according to StockValueFinder's criteria.

**Example:** If Company X has an EPS of $2 last year and $3 this year, while Company Y had an EPS of $1.50 last year but only $1 this year, investors would likely prefer Company X due to its consistent growth in earnings per share.

#### ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is a key measure of how efficiently a company uses capital to generate returns. A higher ROIC indicates better use of resources and stronger profitability relative to the amount invested. Medtronic PLC's ROIC stands at 6.20%, which did not pass StockValueFinder’s preferred threshold of 10% or higher.

**Example:** If Company Z has a ROIC of 15%, it means that for every dollar of capital invested, the company generates $0.15 in profit after taxes and interest expenses. In contrast, if another firm only achieves a ROIC of 4%, it suggests less efficient use of capital.

#### Interest Coverage and Financial Safety

Interest coverage ratio is a measure of how easily a company can pay its interest obligations on outstanding debt with its operating income. StockValueFinder prefers an interest coverage ratio of at least 6, indicating that the firm has sufficient earnings to cover its interest expenses multiple times over. Medtronic PLC passed this test.

**Example:** A company with an interest coverage ratio of 8x can comfortably pay off $8 in earnings for every dollar of interest expense it incurs, whereas a company with only 2x coverage is more vulnerable if interest rates rise or income drops.

#### Debt Payback and Balance Sheet Discipline

The debt payback period measures how long it would take a company to repay all its outstanding debt using current operating cash flow. StockValueFinder prefers companies that can repay their debts within three years, indicating financial discipline and lower risk of default. Medtronic PLC's debt payback period is 4.81 years, which did not pass the test.

**Example:** A firm with a debt payback period of 1.5 years indicates it could clear its debt relatively quickly, whereas a company needing 7 years to repay debts faces greater financial risk and less flexibility in managing cash flow.

#### P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio is a valuation metric that compares the market price of a stock with its earnings per share. StockValueFinder prefers companies trading at P/E ratios below 15 to ensure they are not overvalued relative to their earnings potential. Medtronic PLC's current P/E ratio stands at 23.28, which did not pass this test.

**Example:** A company valued at a P/E of 8 suggests that investors expect the firm’s earnings to grow significantly in the future, whereas a P/E of 40 might indicate high expectations or overvaluation concerns.

#### Moving Average Trend and Entry Timing

The moving average trend signal provides insight into whether a stock is currently trending upwards or downwards. For Medtronic PLC, StockValueFinder's system indicates a "STRONG BUY TREND," suggesting that the stock has been performing well recently. However, it’s important to note that this does not guarantee future performance and should be used alongside other metrics for informed decision-making.

**Example:** A strong buy trend might indicate favorable short-term conditions but doesn’t ensure long-term growth or profitability trends will remain positive.

#### Overall Financial Strengths and Weaknesses

Medtronic PLC demonstrates financial safety through its interest coverage ratio, showing the firm has sufficient earnings to cover debt obligations comfortably. However, the company falls short in terms of EPS consistency, ROIC efficiency, debt payback period, and P/E valuation discipline, indicating areas where it may face challenges or risks.

#### Risks and Limitations

Investing in Medtronic PLC involves several risks including market volatility, regulatory changes affecting medical device industries, technological obsolescence, competition from new entrants, and economic downturns impacting healthcare spending. Additionally, the limitations of StockValueFinder's metrics should be considered; while they provide valuable insights, they do not account for qualitative factors such as management quality or industry-specific dynamics.

#### Educational Conclusion

This article has provided an in-depth analysis of Medtronic PLC using StockValueFinder’s analytical framework, highlighting both strengths and weaknesses based on financial metrics. Understanding these metrics helps investors make informed decisions by identifying companies with strong fundamentals versus those facing potential challenges. However, it is crucial to remember that no single metric or scoring system can predict future performance with certainty.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Max Qwen II editorial portrait
Max Qwen II
Austrian Monetary Analyst · StockValueFinder Editorial Persona

Specializing in monetary economics, market incentives, and investment risk.

Scroll to Top